Department of Radiology, University of Cambridge School of Clinical Medicine.
Email: Bala Attili Tel : +44 (0)1223746574
Bala Attili is a Research Associate at Department of Radiology. He completed his PhD research on “Evaluation of Novel PET ligands for imaging Neuroinflammation” under the guidance of Prof. Guy Bormans at Radiopharmaceutical Research, KU Leuven, Belgium.
During his PhD he worked with organic synthesis of precursor and references, radiolabelling, preclinical evaluation in rodents and monkeys. PET imaging, C-11, F-18 and Ga-68 radiochemistry validations in GMP setup. Writing protocols, reviewing scientific literature, writing scientific articles.
|Degree||Awarding Institution||Field of Study||Graduated|
|PhD||KU Leuven, Belgium||Radiopharmaceutical Sciences||2018|
His current research involves development and evaluation of F-18 and Ga-68 based radiopharmaceuticals for diagnosis and therapy follow-up in clinical use.
Development of novel PET tracers for oncological imagining. Identification of novel targets/tracers combination for the estimation of densities of biomarkers in healthy and pathological conditions.
Attili, S.Celen, M. Ahamed, M.Koole, C. Van den Haute, et al., Preclinical evaluation of [18F]MA3, a CB2 receptor agonist radiotracer for Positron Emission Tomography (2019), British Journal of Pharmacology, https://doi.org/10.1111/bph.14564
Vermeulen, E. Naus, M. Ahamed, B. Attili, M. Siemons, et al., Evaluation of [11C]NMS-E973 as a PET tracer for in vivo visualisation of HSP90 (2019), Theranostics 9(2):554-572.
Ahamed*, B. Attili*, D. van Veghel, M. Ooms, P. Berben, et al., Synthesis and preclinical evaluation of [11C]MA-PB-1 for in vivo imaging of brain monoacylglycerol lipase (MAGL) (2017), Eur. J. Med. Chem. 136. (*Shared first author).
Ooms, B. Attili, S. Celen, M. Koole, A. Verbruggen, et al., [18F]JNJ42259152 binding to phosphodiesterase 10A, a key regulator of medium spiny neuron excitability, is altered in the presence of cyclic AMP (2016), J. Neurochem 139(5):897-906.